Kyoto, Japan

Minako Hoshi

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 1.4

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2013-2017

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Mind of Minako Hoshi: Pioneering Solutions for Neurotoxicity

Introduction: Minako Hoshi, an accomplished inventor based in Kyoto, Japan, has made significant strides in the field of neurobiology. With a remarkable portfolio of three patents, her work is focused on tackling the multifaceted challenges posed by neurotoxic agents, particularly those related to Alzheimer’s disease and other neurodegenerative conditions.

Latest Patents: Among her latest contributions, Hoshi holds patents for a neurotoxic target for amylospheroid, a method and material for reducing the neurotoxicity of amylospheroid, and a method for producing synthetic amylospheroid. The first patent details a target molecule that binds to amylospheroid, leading to the death of mature neurons. Hoshi's second patent presents a method for inhibiting this detrimental effect, utilizing proteins like Na/K-ATPase α3 to block the harmful interaction. Her third patent outlines an efficient method for producing synthetic amylospheroids, which could play a pivotal role in understanding and potentially mitigating neurodegenerative diseases.

Career Highlights: Minako Hoshi has established herself as a leader in her field through her innovative research and patents. Being affiliated with Tao Health Life Pharma Co., Ltd., her work combines scientific expertise with practical applications aimed at improving health outcomes for individuals suffering from neurodegenerative diseases. Her efforts are not only advancing scientific understanding but are also paving the way for potential therapies.

Collaborations: Throughout her career, Hoshi has collaborated with notable colleagues such as Michio Sato and Shoji Ideno. These partnerships have enhanced her research capabilities, allowing her to explore varied approaches to neurotoxicity and collaborate on innovative solutions in the field of neurobiology.

Conclusion: Minako Hoshi stands out as a visionary inventor whose research is shaping the future of neurobiology. Her commitment to addressing the challenges associated with neurotoxicity, particularly in the context of Alzheimer's disease, highlights the importance of innovative thinking in the pursuit of medical advancements. With her patents, Hoshi is not only contributing to scientific knowledge but also opening doors for new treatment modalities that could positively impact countless lives.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…